115 related articles for article (PubMed ID: 7376201)
21. Induction of liver microsomal epoxide hydrolase, UDP-glucuronyl transferase and cytosolic glutathione transferase in different rodent species by 2-acetylaminofluorene or 3-methylcholanthrene.
Aström A; Månér S; DePierre JW
Xenobiotica; 1987 Feb; 17(2):155-63. PubMed ID: 3105187
[TBL] [Abstract][Full Text] [Related]
22. Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: role of metabolism.
Graichen ME; Dent JG
Carcinogenesis; 1985 Jul; 6(7):977-81. PubMed ID: 4017177
[TBL] [Abstract][Full Text] [Related]
23. Selective induction of microsomal 2-acetylaminofluorene N-hydroxylation by dietary 2-acetylaminofluorene in rats.
Sato M; Yoshida T; Suzuki Y; Degawa M; Hashimoto Y
Carcinogenesis; 1981; 2(7):571-4. PubMed ID: 7023732
[TBL] [Abstract][Full Text] [Related]
24. Specific labelling of microsomal proteins by reactive intermediates generated from 2-acetylaminofluorene in vitro.
Kaderbhai MA; Bradshaw TK; Freedman RB
Chem Biol Interact; 1981 Aug; 36(2):211-27. PubMed ID: 7273244
[TBL] [Abstract][Full Text] [Related]
25. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
Wroblewski VJ; Gessner T; Olson JR
Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
[TBL] [Abstract][Full Text] [Related]
26. Effect of cytochrome P450 inducers on liver microsomal metabolism of tetrachlorobiphenyls in rats, guinea pigs and hamsters.
Koga N; Kikuichi-Nishimura N; Yoshimura H
Biol Pharm Bull; 1995 May; 18(5):705-10. PubMed ID: 7492987
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 2-acetylaminofluorene oxidations by monoclonal antibodies specific to 3-methylcholanthrene-induced rat liver cytochrome P450.
Thorgeirsson SS; Sanderson N; Park SS; Gelboin HV
Carcinogenesis; 1983; 4(5):639-41. PubMed ID: 6850996
[TBL] [Abstract][Full Text] [Related]
28. Mixed function oxidase in the mammary gland and liver microsomes of lactating rats. Effects of 3-methylcholanthrene and beta-naphthoflavone.
Ritter CL; Malejka-Giganti D
Biochem Pharmacol; 1982 Jan; 31(2):239-47. PubMed ID: 6277340
[TBL] [Abstract][Full Text] [Related]
29. Prevention of 2-acetylaminofluorene-induced loss of nuclear envelope cytochrome P450 by the simultaneous administration of 3-methylcholanthrene.
Carubelli R; Graham SA; McCay PB; Friedman FK
Biochem Pharmacol; 1991 May; 41(9):1331-4. PubMed ID: 2018565
[TBL] [Abstract][Full Text] [Related]
30. Effects of safrole and isosafrole pretreatment on N- and ring-hydroxylation of 2-acetamidofluorene by the rat and hamster.
Lotlikar PD; Wasserman MB
Biochem J; 1972 Oct; 129(4):937-43. PubMed ID: 4655827
[TBL] [Abstract][Full Text] [Related]
31. Antibody inhibition of oxidative activation and inactivation of the carcinogen 2-acetylaminofluorene by purified hepatic cytochrome P-450 from 3-methylcholanthrene pretreated rats.
Pandey RN; Clearfield MS; Paik SM; Lotlikar PD
Cancer Lett; 1983 Jul; 19(3):263-71. PubMed ID: 6411328
[TBL] [Abstract][Full Text] [Related]
32. Phospholipid requirement for 2-acetamidofluorene N-and ring-hydroxylation by hamster liver microsomal cytochrome P-450 enzyme system.
Lotlikar PD; Dwyer EN; Baldy WJ; Nyce J
Biochem J; 1977 Dec; 168(3):571-4. PubMed ID: 606254
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation.
Burke MD; Prough RA; Mayer RT
Drug Metab Dispos; 1977; 5(1):1-8. PubMed ID: 13970
[TBL] [Abstract][Full Text] [Related]
34. The suppressive effect of hepatic 9,000 x G supernatant fraction from 3-methylcholanthrene-treated rats on the mutagenic activity of 2-acetylaminofluorene.
Kojima A; Kawano S; Hiraga K
Jpn J Pharmacol; 1980 Aug; 30(4):421-6. PubMed ID: 7206358
[TBL] [Abstract][Full Text] [Related]
35. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
36. Ribosomal and microsomal RNase activities in rat liver after methylcholanthrene administration.
Pousada CR; Lechner MC
Biochem Pharmacol; 1972 Oct; 21(19):2563-9. PubMed ID: 4661617
[No Abstract] [Full Text] [Related]
37. Specific modification of the properties of the N-hydroxylase. Relationship with carcinogenesis by aromatic amides.
Razzouk C; Roberfroid M; Mercier M
Arch Toxicol Suppl; 1978; (1):291-4. PubMed ID: 277117
[TBL] [Abstract][Full Text] [Related]
38. Induction and modification of rat liver microsomal arylamide N-hydroxylase by various pretreatments.
Razzouk C; Batardy-Grégoire M; Roberfroid M
Mol Pharmacol; 1982 Mar; 21(2):449-57. PubMed ID: 7099145
[TBL] [Abstract][Full Text] [Related]
39. The effect of pretreating rats with 3-methylcholanthrene upon the enhancement of microsomal aniline hydroxylation by acetone and other agents.
Powis G; Boobis AR
Biochem Pharmacol; 1975 Feb; 24(3):424-6. PubMed ID: 1125053
[No Abstract] [Full Text] [Related]
40. Role of dietary corn oil in the function of hepatic drug and carcinogen metabolizing enzymes of starved-refed rats: response to the mixed function oxidase inducer, 3-methylcholanthrene.
Wade AE; Bellows J
J Environ Pathol Toxicol Oncol; 1987; 7(3):11-9. PubMed ID: 3559914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
